MJ
MJNA.US Medical Marijuana I
- Market cap
- USD 1.39M
- P/E
- -
- P/B
- 0.59x
- ROE
- 0.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is MJNA.US undervalued?
Graham numberThe Graham number of Medical Marijuana I cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Medical Marijuana I fundamental analysis
No fundamental analysis for Medical Marijuana I yet.
Medical Marijuana I stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Medical Marijuana I
Medical Marijuana, Inc., an investment holding company, operates in the cannabinoid-based nutraceutical industry. It engages in creating international CBD pipeline; produces legal cannabis products; develops cannabis drug and medication; supports services for cannabis industry; and develops market for medical cannabis. Medical Marijuana, Inc. was incorporated in 2005 and is based in Vista, California.
Full company profileMedical Marijuana I financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Medical Marijuana I annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 8.00M | 26.5M | 59.8M | 75.6M | 46.9M | 34.1M | 25.1M | 16.8M | 14.9M | 12.5M | 9.65M |
| Gross Profit | 4.64M | 18.4M | 40.3M | 57.7M | 37.7M | 26.9M | 18.5M | 11.2M | 11.7M | 9.07M | 7.81M |
| Operating Income | -4.40M | -3.96M | -9.54M | 1.42M | -2.15M | -1.78M | -4.70M | -4.49M | -1.13K | -905K | -861K |
| EBITDA | -14.2M | -135M | -9.42M | 1.12M | -95.0M | -4.04M | -14.9M | -4.72M | -74.0K | -717K | -675K |
| Net Income | -25.9M | -148M | -203M | 84.4M | -95.8M | -4.77M | -15.3M | -5.08M | -642K | -935K | 292K |
| EPS | -0.01 | -0.05 | -0.06 | 0.02 | -0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 394M | 275M | 93.0M | 180M | 84.3M | 80.7M | 68.9M | 69.6M | 67.8M | 66.3M | 67.1M |
| Total Liabilities | 12.7M | 15.5M | 24.4M | 23.3M | 19.0M | 11.6M | 14.3M | 19.6M | 18.0M | 16.5M | 17.0M |
| Shareholders' Equity | 381M | 259M | 68.5M | 156M | 65.3M | 69.1M | 54.6M | 49.9M | 49.8M | 49.8M | 50.1M |
| Cash & Short-term Investments | 1.11M | 2.29M | 5.36M | 6.21M | 6.30M | 5.45M | 737K | 674K | 1.03M | 749K | 699K |
| Total Debt | 11.7M | 14.8M | 17.0M | 12.3M | 10.2M | 4.80M | 7.65M | 3.70M | 2.85M | 2.51M | 3.13M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -19.6M | -155M | -198M | 86.3M | -95.9M | -4.48M | -14.8M | -2.54M | 977K | -1.35M | 1.58M |
| Capital Expenditure | 315K | 45.4M | 315K | 638K | 0.00 | 24.0K | 2.86M | 4.36M | 1.00 | 5.00 | 12.00 |
| Free Cash Flow | -19.6M | -200M | -198M | 85.6M | -95.9M | -4.50M | -17.6M | -6.90M | 977K | -1.35M | 1.58M |
| Ratios | |||||||||||
| ROE | -6.8% | -57.1% | -296.2% | 54.0% | -146.6% | -6.9% | -28.1% | -10.2% | -1.3% | -1.9% | 0.6% |
| ROA | -6.6% | -53.9% | -218.3% | 47.0% | -113.6% | -5.9% | -22.3% | -7.3% | -0.9% | -1.4% | 0.4% |
| Net Profit Margin | -323.7% | -558.4% | -339.2% | 111.7% | -204.1% | -14.0% | -61.2% | -30.2% | -4.3% | -7.5% | 3.0% |
| Debt to Equity | 0.03x | 0.06x | 0.25x | 0.08x | 0.16x | 0.07x | 0.14x | 0.07x | 0.06x | 0.05x | 0.06x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Medical Marijuana I dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | USD 112K | 0.00 | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 10:1 on Apr 28, 2009.
Who owns Medical Marijuana I
- Insiders 0.00%
- Institutions 0.00%
- Public & others 100.00%
- Shares outstanding 13.9B
- Free float 3.38B
Medical Marijuana I company profile
- Company name
- Medical Marijuana I
- Ticker
- MJNA.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 91
- Fiscal year end
- December
- Address
- 2384 La Mirada Drive, Vista, CA, United States, 92081
- Phone
- 866 273 8502
- Website
- medicalmarijuanainc.com
About Medical Marijuana I
Medical Marijuana, Inc., an investment holding company, operates in the cannabinoid-based nutraceutical industry. It engages in creating international CBD pipeline; produces legal cannabis products; develops cannabis drug and medication; supports services for cannabis industry; and develops market for medical cannabis. Medical Marijuana, Inc. was incorporated in 2005 and is based in Vista, California.
Medical Marijuana I management
5- Dr. Timothy Richard Scott Ph.D.CEO, President & Chairman · born 1953
- Mr. Tyler WhatcottChief Technology Officer
- Ms. Michelle L. Sides Esq.Chief Legal Officer
- Dr. Rubens WajnsztejnChief Medical Officer
- Dr. George E. Anastassov DDS, M.D., MBAMember of Advisory Board and Chief Executive Officer of Canchew Biotechnologies · born 1963